Skip to main content
Clinical Trials/CTRI/2026/02/102668
CTRI/2026/02/102668Not yet recruitingPhase 2

Efficacy of intradermal methylene blue infiltration on postoperative analgesia in haemorrhoidectomy - a randomized control study

Rishi Middha1 site in 1 country84 target enrollmentStarted: February 12, 2026Last updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Enrollment
84
Locations
1

Study Overview

Brief Summary

THIS STUDY IS BEING DONE IN AN EFFORT TO REDUCE THE POST OPERATIVE PAIN AND THE NEED FOR POST OPERATIVE ANALGESIA IN CASE OF HAEMORRHOIDECTOMY WITH THE HYPOTHESIS BEING THAT INTRADERMAL PERIANAL INFILTRATION OF METHYLENE BLUE RESULTS IN A DECREASE IN THE POSTOPERATIVE PAIN DUE TO TEMPORARY ABLATION OF CUTANEOUS NERVE ENDINGS BY BLOCKING VOLTAGE GATED SODIUM CHANNELS

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
Participant Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 80.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients undergoing haemorrhoidectomy in KIMS, Deparment of General Surgery.

Exclusion Criteria

  • Pregnant and Breast feeding female.
  • Allergic to Methlene Blue.
  • Patient having any other perianal condition.
  • Patient not giving consent to be a part of the study.

Investigators

Sponsor
Rishi Middha
Sponsor Class
Other [SELF FUNDED]
Responsible Party
Principal Investigator
Principal Investigator

Sushanta Kumar Das

Kalinga Institute of Medical Sciences

Study Sites (1)

Loading locations...

Similar Trials